국가: 이스라엘
언어: 영어
출처: Ministry of Health
BIMATOPROST
TEVA ISRAEL LTD
S01EE03
OPHTHALMIC SOLUTION
BIMATOPROST 0.3 MG / 1 ML
OCULAR
Required
TEVA ISRAEL LTD, ISRAEL
BIMATOPROST
Reduction of elevated intraocular pressure in chronic open angle glaucoma and ocular hypertension (as monotherapy or as adjunctive therapy to beta-blockers).
2023-10-31
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986 THE MEDICINE IS DISPENSED WITH A DOCTOR’S PRESCRIPTION ONLY BIMATOPROST TEVA EYE DROPS, SOLUTION ACTIVE INGREDIENT: Each 1 ml contains: Bimatoprost 0.3 mg For information regarding inactive ingredients and allergens in the medicine, see section 2 - “Important information about some of the ingredients of the medicine” and section 6 - “Additional information”. READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE. This leaflet contains concise information about the medicine. If you have additional questions, refer to the doctor or the pharmacist. This medicine has been prescribed for treatment of your illness. Do not pass it on to others. It may harm them even if it seems to you that their illness is similar. 1. WHAT IS THE MEDICINE INTENDED FOR? Bimatoprost Teva is intended for lowering intra-ocular pressure in patients with chronic open-angle glaucoma as a monotherapy or in combination with eye drops containing beta-blocking agents. THERAPEUTIC CLASS: prostaglandin analogs called prostamides. The eye contains a clear and watery fluid that nourishes the eye’s interior. The fluid drains out of the eye regularly and new fluid is produced to replace it. If the fluid cannot drain out sufficiently fast, pressure builds up inside the eye. The medicine acts by increasing the amount of fluid drained. This way the pressure inside the eye is reduced. If the high pressure is not reduced, it can lead to an illness called glaucoma and eventually impair your eyesight. 2. BEFORE USING THE MEDICINE DO NOT USE THIS MEDICINE IF: • You are sensitive (allergic) to bimatoprost or to any of the other ingredients this medicine contains (see section 2 – “Important information about some of the ingredients of the medicine” and section 6 - “Additional information”). • You were previously required to stop using eye drops due to side effects that result from the preservative benzalkonium chloride. SPECIAL WARNINGS REGARDI 전체 문서 읽기